![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Buy article online]](/logos/buy.gif)
![[Contents scheme]](wn2124contents.gif)
Acta Cryst. (2007). E63, m1385-m1387 [ doi:10.1107/S160053680701687X ]
Abstract: The title compound, [Fe(C5H5)(C11H13N2O)]·[Fe(C5H5)(C11H13N2O)]Cl, cocrystallizes as (1-2-hydroxyethyl-5-methylpyrazol-3-yl)ferrocenium chloride-(1-2-hydroxyethyl-5-methylpyrazol-3-yl)ferrocene (1/1). Two independent pyrazolylferrocenes in the asymmetric unit, with similar geometric parameters, form an R44(24) tetramer via O-H
N hydrogen bonds and Cl- ions occupy the spaces between the tetramer rings. This tetramer is linked via C-H
hydrogen bonds, involving the cyclopentadienyl rings as acceptors, into a [100] chain.
Online 20 April 2007
Copyright © International Union of Crystallography
IUCr Webmaster